Docoh
Loading...

IINN Inspira Technologies Oxy B.H.N.

Filed: 23 Nov 21, 6:09am

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of: November 2021 (Report No. 2)

 

Commission File Number: 001-40303

 

Inspira Technologies Oxy B.H.N. Ltd.

(Translation of registrant’s name into English)

 

2 Ha-Tidhar St.

Ra’anana 4366504, Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

 Form 20-F       Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  

 

 

 

 

 

CONTENTS

 

On November 22, 2021, Inspira Technologies Oxy B.H.N. Ltd., or the Registrant, issued a press release titled “Dr. Stephane Ledot, an Expert in Critical Care and Anesthesia, Has Joined Inspira Technologies’ Scientific Advisory Board,” a copy of which is furnished as Exhibit 99.1 with this report of foreign private issuer on Form 6-K.

 

The first two and the fourth, fifth, sixth and seventh paragraphs and the section titled “Forward-Looking Statements” in the press release are incorporated by reference into the Registrant’s Registration Statement on Form S-8 (Registration No. 333-259057), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. 

 

Exhibit No.  
99.1 Press Release issued by Inspira Technologies Oxy B.H.N. Ltd. on November 22, 2021, titled “Dr. Stephane Ledot, an Expert in Critical Care and Anesthesia, Has Joined Inspira Technologies’ Scientific Advisory Board.”

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 Inspira Technologies Oxy B.H.N. Ltd.
   
Date: November 23, 2021By:/s/ Dagi Ben-Noon
  Name: Dagi Ben-Noon
  Title:Chief Executive Officer